Harold "E.B." Brakewood

CBO at Immuneering Corporation

Speaker

Harold E. Brakewood ("E.B.") has served as Immuneering's Chief Business Officer since March 2023.He joined Immuneering from Regeneron Pharmaceuticals where he most recently served as Vice President, Business Unit Head for oncology, Covid19, and new product planning. At Regeneron his teams launched three medicines in six indications in the U.S. and globally, including the anti-PD1 Libtayo for patients with advanced cancers. Prior to Regeneron, Mr. Brakewood held several positions of increasing responsibility over 20 years at Merck (MSD), including strategic planning during the launch of Keytruda, business development, brand management, and leadership of an oncology start-up venture. Mr. Brakewood received an MBA from Harvard Business School, an M.A. in physics from Dartmouth College and a B.A. in physics from Bowdoin College.